Download references

Open Access

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

Malek B Hannouf, Bin Xie, Muriel Brackstone and Gregory S Zaric*

BMC Cancer 2012, 12:447  doi:10.1186/1471-2407-12-447

Include


Format